Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer
Clinical trial NCT00193102 · TERMINATED
Trial details
- NCT number
- NCT00193102
- Sponsor
- SCRI Development Innovations, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-04-01
- Primary completion
- 2005-02-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.